华佗品牌怎么样 申请店铺

我要投票 华佗在中草药行业中的票数:25 更新时间:2024-11-22
华佗是哪个国家的品牌?「华佗」是 华佗国药股份有限公司 旗下著名品牌。该品牌发源于安徽,由创始人李宏良在2009期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
华佗怎么样

安徽华佗国药股份有限公司位于三朝古都,华佗故里,中国历史文化名城,全国四大药都之首—安徽省亳州市。安徽华佗国药股份有限公司已有50多年建厂历史,设计规模及生产能力居安徽前列,在全国也位列前茅;2001年又斥资上亿元,由省医药设计院,参照中外合资先进企业的优点和特色,经科学规划、精心设计、高标准建设、全面实施国家医药GMP工程,并于2002年12月8日一次性通过国家GMP认证,是国内第一批通过GMP认证的企业之一。

致力于发展传统的中医药文化,倡导安全用药,安心用药,秉承“用良心制好药”的理念,华佗国药厂自始就以质量控制为第一要务,厂内配有全进口日本岛津公司高效液相仪、气相色谱仪、薄层扫描仪、紫光分析仪等检测设备,堪称高起点,高标准的现代化中成药制造企业和中药材加工基地。厂内现有国内领先的全自动生产灌装线、自动颗粒包装机、自动胶囊填充机、自动铝塑包装机、全自动高效包衣机等现代化设备均完全符合国家GMP标准。并配有空压冷冻系统、净化系统、电视监控系统、数字化管理等一系列先进管理系统;为了进一步的提高中药现代化的进程,我们成立了安徽华佗现代中药研发中心,致力于中国中药现代化的研究与开发。

安徽华佗国药股份有限公司,目前具有年加工中药材5600吨的生产能力,产品有片剂、丸剂、胶囊剂、颗粒剂、单味药颗粒、中药饮片六大剂类型,60多个品种,年产值可达5.6亿元,产品大部分出口,畅销亚、欧、美三十多个国家和地区。在不久的将来,安徽华佗国药股份有限公司将成为中国最大的中成药生产企业和中药材加工基地。

在华佗国药厂的发展历史上,曾受到诸多中央和省市领导人的关心,国务院总理温家宝、副总理回良玉及安徽省历届主要党政领导人曾亲自前往华佗国药厂视察。

安徽华佗国药股份有限公司始终坚持“质量第一,诚信为本,用良心制好药”的经营理念,确保人民安全用药,保障人民身体健康,促进医药经济发展。竭诚欢迎海内外客商来厂洽谈业务,进行经贸合作。

Anhui Huatuo State Pharmaceutical Co., Ltd. is located in Bozhou City, Anhui Province, the capital of three dynasties, the hometown of Huatuo, the famous historical and cultural city of China and the first of the four major pharmaceutical capitals in China. Anhui Huatuo State Pharmaceutical Co., Ltd. has a history of more than 50 years. Its design scale and production capacity rank the top in Anhui Province, and it ranks the top in the country. In 2001, it also spent more than 100 million yuan. With reference to the advantages and characteristics of advanced Sino foreign joint ventures, the Provincial Pharmaceutical Design Institute carried out the national pharmaceutical GMP project through scientific planning, careful design, high standard construction and comprehensive implementation One time through the national GMP certification, is the first batch of domestic enterprises through GMP certification. Committed to the development of traditional Chinese medicine culture, advocating safe drug use, reassuring drug use, and adhering to the concept of "making good medicine with conscience", huatuoguo pharmaceutical factory has been focusing on quality control since the beginning. The factory is equipped with imported high-performance liquid chromatography, gas chromatograph, thin-layer scanner, violet light analyzer and other testing equipment of Shimadzu company of Japan, which can be regarded as a high starting point and a high standard of modernization Pharmaceutical manufacturing enterprises and traditional Chinese medicine processing bases. In the factory, the domestic leading full-automatic production filling line, automatic particle packaging machine, automatic capsule filling machine, automatic aluminum plastic packaging machine, automatic high-efficiency coating machine and other modern equipment are all in full compliance with the national GMP standards. In order to further improve the modernization process of traditional Chinese medicine, we have established Anhui Huatuo modern Chinese medicine research and development center, which is dedicated to the research and development of the modernization of traditional Chinese medicine. Anhui Huatuo State Pharmaceutical Co., Ltd. has an annual production capacity of processing 5600 tons of Chinese herbal medicines. Its products include six types of tablets, pills, capsules, granules, single drug granules and Chinese herbal pieces, with more than 60 varieties. Its annual output value can reach 560 million yuan. Most of its products are exported and sold well in more than 30 countries and regions in Asia, Europe and the United States. In the near future, Anhui Huatuo Guoyao Co., Ltd. will become the largest Chinese patent medicine manufacturer and Chinese herbal medicine processing base in China. In the development history of Huatuo state pharmaceutical factory, it has been concerned by many central and provincial leaders. Premier Wen Jiabao of the State Council, Vice Premier Hui Liangyu and major party and government leaders of Anhui Province have personally visited Huatuo state pharmaceutical factory. Anhui Huatuo State Pharmaceutical Co., Ltd. always adheres to the business philosophy of "quality first, integrity-based, making good medicine with conscience", so as to ensure people's safe drug use, ensure people's health and promote the development of medical economy. We sincerely welcome customers from home and abroad to come to our factory to discuss business and carry out economic and trade cooperation.

本文链接: https://brand.waitui.com/e16df2ef3.html 联系电话:0551-4669444

千城特选小程序码

7×24h 快讯

私募购买年内上市ETF近30亿份

私募排排网统计数据显示,截至11月22日,共有126家私募证券管理人旗下产品进入到107家年内上市ETF前十大持有人名单中,合计持有份额达29.57亿份。(界面)

5分钟前

外交部:进一步扩大免签国家范围并优化入境政策

36氪获悉,据外交部领事司,为进一步便利中外人员往来,中方决定扩大免签国家范围,自2024年11月30日起至2025年12月31日,对保加利亚、罗马尼亚、克罗地亚、黑山、北马其顿、马耳他、爱沙尼亚、拉脱维亚、日本持普通护照人员试行免签政策。此外,中方决定同步优化入境政策,将交流访问纳入免签事由,将免签停留期限自现行15日延长至30日。自2024年11月30日起,包括上述9国在内的38个免签国家持普通护照人员来华经商、旅游观光、探亲访友、交流访问、过境不超过30天,可免办签证入境。不符合免签条件人员仍需在入境前办妥来华签证。

5分钟前

中国汽车流通协会:预计11月狭义乘用车零售市场约为240万辆

36氪获悉,据中国汽车流通协会,最新调研结果显示,11月月中整体车市折扣率约为24.1%,环比上月基本持平,终端优惠及促销政策力度无明显变化。零售量占总市场近八成的头部厂商本月零售目标环比增幅约6.5%,初步推算本月狭义乘用车零售总市场规模约为240.0万辆左右,同比去年增长15.4%,环比上月增长6.1%,新能源零售预计可达128.0万,渗透率约53.3%。

5分钟前

越南电动车商VinFast母公司成立机器人研发应用企业VinRobotics

当地时间11月20日,越南电动车商VinFast母公司Vin集团宣布成立“VinRobotics机器人研发与应用股份公司”,法定资本为10万亿越南盾(约合4000万美元)。Vin集团持有新公司51%的股份,Vin集团创始人范日旺持股39%。(界面)

5分钟前

康为世纪:幽门螺杆菌耐药基因检测试剂盒获得III类医疗器械注册证

36氪获悉,康为世纪发布公告,全资子公司健为诊断自主研发生产的幽门螺杆菌耐药基因检测试剂盒(基于粪便样本)收到国家药品监督管理局颁发的III类《医疗器械注册证》。

6分钟前

本页详细列出关于百灵鸟的品牌信息,含品牌所属公司介绍,百灵鸟所处行业的品牌地位及优势。
咨询